Which of the “Six Foods” Would You Eliminate First?

Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

ACAAI 2024. Two studies here showed that anaphylaxis protocols for EMS are outdated in many states and that many patients don't know how to use epinephrine.

The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.